AbbVie has launched its Produodopa for Parkinson’s in the EU, becoming the first and only 24-hour levodopa-based subcutaneous infusion therapy for the disease.

AbbVie has finally claimed FDA approval for its advanced Parkinson's disease therapy Vyalev, 18 months after the US regulator turned it down with a request for more data.

"Well, one MRI later, and they discovered that her little spine-adjacent cyst was actually an ovarian cyst. The anatomically ...

As a technology broadcaster and journalist, largely for the BBC, I've spent the best part of two decades deeply immersed in ...

Convatec announced that it received FDA approval for the delivery of a Parkinson's disease therapy through its Neria Guard ...

A drug used for Parkinson's disease has been shown to be effective in reducing the symptoms of difficult to treat depression, ...

Researchers are using an advanced brain imaging method called MEG to understand why Parkinson’s drug levodopa doesn’t work ...

Simon Fraser University researchers are using a new approach to brain imaging that could improve how drugs are prescribed to ...

Despite a significant improvement in symptoms, around 20% of patients discontinued treatment due to adverse events.

Every year, tens of thousands of people with signs of Parkinson's disease go unnoticed until the incurable neurodegenerative ...

A pharmacist has issued a heatwave health warning to anyone taking five specific medications. Dipa Kamdar ... Beta-blockers lower heart rate and reduce how forcefully the heart pumps. However Ms ...